143 related articles for article (PubMed ID: 30468864)
1. SIL1 deficiency causes degenerative changes of peripheral nerves and neuromuscular junctions in fish, mice and human.
Phan V; Cox D; Cipriani S; Spendiff S; Buchkremer S; O'Connor E; Horvath R; Goebel HH; Hathazi D; Lochmüller H; Straka T; Rudolf R; Weis J; Roos A
Neurobiol Dis; 2019 Apr; 124():218-229. PubMed ID: 30468864
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome.
Kawahara G; Hayashi YK
PLoS One; 2016; 11(10):e0165563. PubMed ID: 27792754
[TBL] [Abstract][Full Text] [Related]
3. Myopathy in Marinesco-Sjögren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology.
Roos A; Buchkremer S; Kollipara L; Labisch T; Gatz C; Zitzelsberger M; Brauers E; Nolte K; Schröder JM; Kirschner J; Jesse CM; Goebel HH; Goswami A; Zimmermann R; Zahedi RP; Senderek J; Weis J
Acta Neuropathol; 2014 May; 127(5):761-77. PubMed ID: 24362440
[TBL] [Abstract][Full Text] [Related]
4. Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders.
Buchkremer S; González Coraspe JA; Weis J; Roos A
J Neuromuscul Dis; 2016 May; 3(2):169-181. PubMed ID: 27854219
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis of Marinesco-Sjogren Syndrome Fibroblasts Indicates Pro-Survival Metabolic Adaptation to SIL1 Loss.
Potenza F; Cufaro MC; Di Biase L; Panella V; Di Campli A; Ruggieri AG; Dufrusine B; Restelli E; Pietrangelo L; Protasi F; Pieragostino D; De Laurenzi V; Federici L; Chiesa R; Sallese M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830330
[TBL] [Abstract][Full Text] [Related]
6. PERK inhibition attenuates the abnormalities of the secretory pathway and the increased apoptotic rate induced by SIL1 knockdown in HeLa cells.
Capone V; Clemente E; Restelli E; Di Campli A; Sperduti S; Ornaghi F; Pietrangelo L; Protasi F; Chiesa R; Sallese M
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3164-3180. PubMed ID: 30293566
[TBL] [Abstract][Full Text] [Related]
7. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome.
Krieger M; Roos A; Stendel C; Claeys KG; Sonmez FM; Baudis M; Bauer P; Bornemann A; de Goede C; Dufke A; Finkel RS; Goebel HH; Häussler M; Kingston H; Kirschner J; Medne L; Muschke P; Rivier F; Rudnik-Schöneborn S; Spengler S; Inzana F; Stanzial F; Benedicenti F; Synofzik M; Lia Taratuto A; Pirra L; Tay SK; Topaloglu H; Uyanik G; Wand D; Williams D; Zerres K; Weis J; Senderek J
Brain; 2013 Dec; 136(Pt 12):3634-44. PubMed ID: 24176978
[TBL] [Abstract][Full Text] [Related]
8. PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome.
Grande V; Ornaghi F; Comerio L; Restelli E; Masone A; Corbelli A; Tolomeo D; Capone V; Axten JM; Laping NJ; Fiordaliso F; Sallese M; Chiesa R
Hum Mol Genet; 2018 Jul; 27(14):2477-2489. PubMed ID: 29718201
[TBL] [Abstract][Full Text] [Related]
9. SIL1, a causative cochaperone gene of Marinesco-Söjgren syndrome, plays an essential role in establishing the architecture of the developing cerebral cortex.
Inaguma Y; Hamada N; Tabata H; Iwamoto I; Mizuno M; Nishimura YV; Ito H; Morishita R; Suzuki M; Ohno K; Kumagai T; Nagata K
EMBO Mol Med; 2014 Mar; 6(3):414-29. PubMed ID: 24473200
[TBL] [Abstract][Full Text] [Related]
10. C-terminal mutations destabilize SIL1/BAP and can cause Marinesco-Sjögren syndrome.
Howes J; Shimizu Y; Feige MJ; Hendershot LM
J Biol Chem; 2012 Mar; 287(11):8552-60. PubMed ID: 22219183
[TBL] [Abstract][Full Text] [Related]
11. SIL1-related Marinesco-Sjoegren syndrome (MSS) with associated motor neuronopathy and bradykinetic movement disorder.
Byrne S; Dlamini N; Lumsden D; Pitt M; Zaharieva I; Muntoni F; King A; Robert L; Jungbluth H
Neuromuscul Disord; 2015 Jul; 25(7):585-8. PubMed ID: 25958341
[TBL] [Abstract][Full Text] [Related]
12. Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco-Sjögren syndrome.
Anttonen AK; Siintola E; Tranebjaerg L; Iwata NK; Bijlsma EK; Meguro H; Ichikawa Y; Goto J; Kopra O; Lehesjoki AE
Eur J Hum Genet; 2008 Aug; 16(8):961-9. PubMed ID: 18285827
[TBL] [Abstract][Full Text] [Related]
13. The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone.
Anttonen AK; Mahjneh I; Hämäläinen RH; Lagier-Tourenne C; Kopra O; Waris L; Anttonen M; Joensuu T; Kalimo H; Paetau A; Tranebjaerg L; Chaigne D; Koenig M; Eeg-Olofsson O; Udd B; Somer M; Somer H; Lehesjoki AE
Nat Genet; 2005 Dec; 37(12):1309-11. PubMed ID: 16282978
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjögren syndrome.
Zhao L; Rosales C; Seburn K; Ron D; Ackerman SL
Hum Mol Genet; 2010 Jan; 19(1):25-35. PubMed ID: 19801575
[TBL] [Abstract][Full Text] [Related]
15. INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH.
Hathazi D; Cox D; D'Amico A; Tasca G; Charlton R; Carlier RY; Baumann J; Kollipara L; Zahedi RP; Feldmann I; Deleuze JF; Torella A; Cohn R; Robinson E; Ricci F; Jungbluth H; Fattori F; Boland A; O'Connor E; Horvath R; Barresi R; Lochmüller H; Urtizberea A; Jacquemont ML; Nelson I; Swan L; Bonne G; Roos A
Brain; 2021 Sep; 144(8):2427-2442. PubMed ID: 33792664
[TBL] [Abstract][Full Text] [Related]
16. Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome.
Ezgu F; Krejci P; Li S; de Sousa C; Graham JM; Hansmann I; He W; Porpora K; Wand D; Wertelecki W; Schneider A; Wilcox WR
Clin Genet; 2014 Jul; 86(1):74-84. PubMed ID: 23829326
[TBL] [Abstract][Full Text] [Related]
17. In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sjögren syndrome.
Kollipara L; Buchkremer S; Coraspe JAG; Hathazi D; Senderek J; Weis J; Zahedi RP; Roos A
Oncotarget; 2017 Sep; 8(40):68493-68516. PubMed ID: 28978133
[TBL] [Abstract][Full Text] [Related]
18. Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.
Filézac de L'Etang A; Maharjan N; Cordeiro Braña M; Ruegsegger C; Rehmann R; Goswami A; Roos A; Troost D; Schneider BL; Weis J; Saxena S
Nat Neurosci; 2015 Feb; 18(2):227-38. PubMed ID: 25559081
[TBL] [Abstract][Full Text] [Related]
19. Novel SIL1 nonstop mutation in a Chinese consanguineous family with Marinesco-Sjögren syndrome and Dandy-Walker syndrome.
Gai N; Jiang C; Zou YY; Zheng Y; Liang DS; Wu LQ
Clin Chim Acta; 2016 Jul; 458():1-4. PubMed ID: 27106665
[TBL] [Abstract][Full Text] [Related]
20. Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy.
Senderek J; Krieger M; Stendel C; Bergmann C; Moser M; Breitbach-Faller N; Rudnik-Schöneborn S; Blaschek A; Wolf NI; Harting I; North K; Smith J; Muntoni F; Brockington M; Quijano-Roy S; Renault F; Herrmann R; Hendershot LM; Schröder JM; Lochmüller H; Topaloglu H; Voit T; Weis J; Ebinger F; Zerres K
Nat Genet; 2005 Dec; 37(12):1312-4. PubMed ID: 16282977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
